Exit

Session 1

Medication Assisted Treatment for Opioid Addiction Among Safety-Sensitive Workers: What Lurks Beneath the Controversy?

Question Title

* 1. Your Name (First and Last, for CE verification only)

Question Title

* 2. Your Email (for CE verification only)

Question Title

* 3. Was this session was fair, balanced and free of commercial bias?

  Yes No
Fair
Balanced
Free of Commercial Bias

Question Title

* 4. Session 1. Medication Assisted Treatment for Opioid Addiction Among Safety-Sensitive Workers: What Lurks Beneath the Controversy?

Rate the effectiveness of the speaker, and state whether the objectives were met.

  Strongly Agree Agree Disagree Strongly Disagree
Chris Bundy was an effective speaker for this session
State the risks, benefits and alternatives of opioid agonist treatment among safety-sensitive workers.
Analyze opioid agonist treatment for safety-sensitive workers from the perspectives of individualized treatment vs. population management.
Discuss how the opioid agonist controversy may be influenced by underlying attitudes and beliefs about the goals of health monitoring.

T